Zileuton is a research area focused on the development and study of a drug called zileuton, which is a leukotriene synthesis inhibitor used primarily for the treatment of asthma. Leukotrienes are inflammatory mediators in the body that can cause airway constriction and inflammation in individuals with asthma. Zileuton works by inhibiting the production of leukotrienes, thereby reducing inflammation and improving breathing function in patients with asthma. Researchers in this area are interested in studying the efficacy and safety of zileuton, as well as exploring its potential use in other inflammatory conditions.